# Impact of Real-time MIC (Minimum Inhibitory Concentration) Reporting (<6 Hours) on β-lactam Prescription in Cases of Gram-negative Bacilli Bacteremia in ICU Patients in Real-life Settings

> **NCT07202377** · NA · NOT_YET_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 200 (estimated)

## Conditions studied

- Gram-negative Bacteremia
- Intensive Care Patients

## Interventions

- **DIAGNOSTIC_TEST:** SPECIFIC REVEAL® Rapid AST system
- **DIAGNOSTIC_TEST:** antibiotic susceptibility testing on agar medium

## Key facts

- **NCT ID:** NCT07202377
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10
- **Primary completion:** 2026-11
- **Final completion:** 2026-11
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07202377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07202377, "Impact of Real-time MIC (Minimum Inhibitory Concentration) Reporting (<6 Hours) on β-lactam Prescription in Cases of Gram-negative Bacilli Bacteremia in ICU Patients in Real-life Settings". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT07202377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*